PHAR40040 Emerging therapies: Cloning, gene therapy and stem cells

Academic Year 2022/2023

This module is core for stage 4 of the BSc degree in Pharmacology. This module investigates modern experimental strategies in the development of Gene-based (silencing, editing, replacement), Cell-Based (stem cell) and Drug-based therapeutic interventions. Specific examples of the application of these emerging approaches to treat inherited and age-related blindness will be critically discussed

Show/hide contentOpenClose All

Curricular information is subject to change

Learning Outcomes:

On completion of this module students: 1. will appreciate the fundamentals of vision and vision loss, 2. comprehend the principles supporting development of gene-,cell- and drug-based therapeutic intervetnions for blindness and 3 demonstrate ability to critica;distinguish progress in development of these approcahes to treat inherited retinal degeneration and age-related macular degeneration.

Student Effort Hours: 
Student Effort Type Hours
Lectures

12
Autonomous Student Learning

90
Total

102
Approaches to Teaching and Learning:
The content is primarily of lectures that cover specific concepts and which direct the students to the primary literature for further study. Introductoy and review lectures are included at the start and mid-way. 
Requirements, Exclusions and Recommendations
Learning Recommendations:

PHAR30050
PHAR30040


Module Requisites and Incompatibles
Incompatibles:
PATH30060 - Genetics,perinatal,paediatric


 
Assessment Strategy  
Description Timing Open Book Exam Component Scale Must Pass Component % of Final Grade
Examination: End of Semester Written Examination 2 hour End of Trimester Exam No Graded No

100

Carry forward of passed components
No
 
Resit In Terminal Exam
Summer Yes - 2 Hour
Please see Student Jargon Buster for more information about remediation types and timing. 
Feedback Strategy/Strategies

• Feedback individually to students, post-assessment

How will my Feedback be Delivered?

Not yet recorded.